Crossref journal-article
Elsevier BV
Journal of Molecular Biology (78)
Bibliography

Kaylor, J., Bodner, N., Edridge, S., Yamin, G., Hong, D.-P., & Fink, A. L. (2005). Characterization of Oligomeric Intermediates in α-Synuclein Fibrillation: FRET Studies of Y125W/Y133F/Y136F α-Synuclein. Journal of Molecular Biology, 353(2), 357–372.

Authors 6
  1. Joanna Kaylor (first)
  2. Nika Bodner (additional)
  3. Shauna Edridge (additional)
  4. Ghiam Yamin (additional)
  5. Dong-Pyo Hong (additional)
  6. Anthony L. Fink (additional)
References 38 Referenced 143
  1. {'key': '10.1016/j.jmb.2005.08.046_bib1', 'first-page': '313', 'article-title': 'Pathobiology of the Lewy body', 'volume': '80', 'author': 'Galvin', 'year': '1999', 'journal-title': 'Advan. Neurol.'} / Advan. Neurol. / Pathobiology of the Lewy body by Galvin (1999)
  2. 10.1126/science.276.5321.2045 / Science / Mutation in the alpha-synuclein gene identified in families with Parkinson's disease by Polymeropoulos (1997)
  3. 10.1038/ng0298-106 / Nature Genet. / Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease by Kruger (1998)
  4. 10.1016/S0014-5793(01)02597-2 / FEBS Letters / Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease by Uversky (2001)
  5. 10.1016/S0161-813X(02)00099-2 / Neurotoxicology / Environmental factors in Parkinson's disease by Di Monte (2002)
  6. 10.1038/42166 / Nature / Alpha-synuclein in Lewy bodies by Spillantini (1997)
  7. 10.1073/pnas.95.11.6469 / Proc. Natl Acad. Sci. USA / Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies by Spillantini (1998)
  8. 10.1126/science.287.5456.1265 / Science / Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders by Masliah (2000)
  9. 10.1038/35006074 / Nature / A Drosophila model of Parkinson's disease by Feany (2000)
  10. 10.1016/0014-5793(94)00395-5 / FEBS Letters / Identification of two distinct synucleins from human brain by Jakes (1994)
  11. 10.1038/40767 / Nature / Familial Parkinson's disease. The awakening of alpha-synuclein by Goedert (1997)
  12. 10.1074/jbc.M010907200 / J. Biol. Chem. / Evidence for a partially folded intermediate in alpha-synuclein fibril formation by Uversky (2001)
  13. 10.1016/S0022-2836(02)00735-0 / J. Mol. Biol. / Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils by Lashuel (2002)
  14. 10.1021/bi030086j / Biochemistry / Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease by Volles (2003)
  15. 10.1074/jbc.M109541200 / J. Biol. Chem. / Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins by Uversky (2002)
  16. 10.1006/abio.1997.2486 / Anal. Biochem. / A new attenuated total reflectance Fourier transform infrared spectroscopy method for the study of proteins in solution by Oberg (1998)
  17. 10.1016/S0076-6879(99)09038-2 / Methods Enzymol. / Fourier transform infrared spectroscopy in analysis of protein deposits by Seshadri (1999)
  18. Fink, A. L. (1999). ANS. In The Encyclopedia of Molecular Biology (Creighton, T. E., ed.), pp. 140–142, Wiley, New York.
  19. 10.1002/andp.19484370105 / Ann. Der Phys. / Zwischenmoleculare energiewanderung und fluoreszenz by Forster (1948)
  20. 10.1016/S0021-9258(18)53581-X / J. Biol. Chem. / Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase–hydrogen peroxide system of human neutrophils and macrophages by Heinecke (1993)
  21. 10.1016/S0006-3495(03)75126-1 / Biophys. J. / FRET or no FRET: a quantitative comparison by Berney (2003)
  22. 10.1021/bi0107694 / Biochemistry / Fluorescence resonance energy transfer shows a close helix-helix distance in the transmembrane M13 procoat protein by Eisenhawer (2001)
  23. 10.1016/S0014-5793(02)02638-8 / FEBS Letters / Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro by Uversky (2002)
  24. 10.1016/S0891-5849(02)00801-8 / Free Radic. Biol. Med. / Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease by Tabner (2002)
  25. 10.1016/S0891-5849(01)00513-5 / Free Radic. Biol. Med. / alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro by Turnbull (2001)
  26. 10.1021/bi027166s / Biochemistry / Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes by Munishkina (2003)
  27. 10.1021/bi049979h / Biochemistry / Role of individual methionines in the fibrillation of methionine-oxidized alpha-synuclein by Hokenson (2004)
  28. 10.1074/jbc.M303302200 / J. Biol. Chem. / Certain metals trigger fibrillation of methionine-oxidized {alpha}-synuclein by Yamin (2003)
  29. 10.1074/jbc.274.28.19509 / J. Biol. Chem. / alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease by Wood (1999)
  30. 10.1073/pnas.97.2.571 / Proc. Natl Acad. Sci. USA / Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy by Conway (2000)
  31. 10.1021/bi026528t / Biochemistry / Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis by Krishnan (2003)
  32. 10.1074/jbc.M000206200 / J. Biol. Chem. / Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies by Souza (2000)
  33. 10.1016/0003-2697(89)90046-8 / Anal. Biochem. / Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T by Naiki (1989)
  34. {'key': '10.1016/j.jmb.2005.08.046_bib34', 'first-page': '768', 'article-title': 'Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: use of the fluorescent indicator, thioflavine T', 'volume': '62', 'author': 'Naiki', 'year': '1990', 'journal-title': 'Lab. Invest.'} / Lab. Invest. / Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: use of the fluorescent indicator, thioflavine T by Naiki (1990)
  35. 10.1021/bi002555c / Biochemistry / Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism by Nielsen (2001)
  36. 10.1021/bi00175a035 / Biochemistry / Nativelike secondary structure in interleukin-1 beta inclusion bodies by attenuated total reflectance FTIR by Oberg (1994)
  37. 10.1016/S0014-5793(03)00367-3 / FEBS Letters / Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers by Yamin (2003)
  38. 10.1111/j.1399-3011.1978.tb02877.x / Int. J. Pept. Protein Res. / Determination of the intramolecular tyrosine-tryptophan distance in a 7-peptide related to the C-terminal sequence of cholecystokinin by Schiller (1978)
Dates
Type When
Created 19 years, 11 months ago (Sept. 7, 2005, 3:11 p.m.)
Deposited 4 years, 1 month ago (July 17, 2021, 1:37 a.m.)
Indexed 5 days, 7 hours ago (Aug. 26, 2025, 3:15 a.m.)
Issued 19 years, 10 months ago (Oct. 1, 2005)
Published 19 years, 10 months ago (Oct. 1, 2005)
Published Print 19 years, 10 months ago (Oct. 1, 2005)
Funders 0

None

@article{Kaylor_2005, title={Characterization of Oligomeric Intermediates in α-Synuclein Fibrillation: FRET Studies of Y125W/Y133F/Y136F α-Synuclein}, volume={353}, ISSN={0022-2836}, url={http://dx.doi.org/10.1016/j.jmb.2005.08.046}, DOI={10.1016/j.jmb.2005.08.046}, number={2}, journal={Journal of Molecular Biology}, publisher={Elsevier BV}, author={Kaylor, Joanna and Bodner, Nika and Edridge, Shauna and Yamin, Ghiam and Hong, Dong-Pyo and Fink, Anthony L.}, year={2005}, month=oct, pages={357–372} }